Drug General Information (ID: DDIN7S56RD)
  Drug Name Miglitol Drug Info Pramlintide Drug Info
  Drug Type Small molecule Small molecule
  Therapeutic Class Antidiabetic Agents Antidiabetic Agents
  Structure

 Mechanism of Miglitol-Pramlintide Interaction (Severity Level: Moderate)
     Altered gastrointestinal dynamics Click to Show/Hide Mechanism Graph
Could Not Find 2D Structure
      Drug Name Miglitol Pramlintide
      Mechanism Absorption is influenced by gastrointestinal motility Decrease gastrointestinal motility
      Key Mechanism Factor 1
Factor Name Gastrointestinal Motility
Factor Description Gastrointestinal motility is an important factor in determining the absorption of orally administered drugs, and it controls the residence time of the drug in the digestive tract.
      Mechanism Description
  • Altered absorption of Miglitol due to GI dynamics variation caused by Pramlintide 

Recommended Action
      Management Due to its effect on gastric emptying, pramlintide therapy should not be considered for patients taking drugs that alter gastrointestinal motility or drugs that slow the intestinal absorption of nutrients.

References
1 Product Information. Symlin (pramlintide). Amphastar Pharmaceuticals Inc, South El Monte, CA.